SCHIZOPHRENIA SPECTRUM AND OTHER PSYCHOTIC DISORDERS
Clinical trials for SCHIZOPHRENIA SPECTRUM AND OTHER PSYCHOTIC DISORDERS explained in plain language.
Never miss a new study
Get alerted when new SCHIZOPHRENIA SPECTRUM AND OTHER PSYCHOTIC DISORDERS trials appear
Sign up with your email to follow new studies for SCHIZOPHRENIA SPECTRUM AND OTHER PSYCHOTIC DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could less medication mean better living for some schizophrenia patients?
Disease control Not yet recruitingThis study looks at whether reducing antipsychotic medication in stable schizophrenia patients can improve their daily functioning compared to staying on the same dose. Researchers will group 288 adults by their specific psychosis type and randomly assign them to either dose redu…
Matched conditions: SCHIZOPHRENIA SPECTRUM AND OTHER PSYCHOTIC DISORDERS
Phase: PHASE2 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
Can a diabetes pill fight antipsychotic weight gain?
Disease control Not yet recruitingThis study tests if dapagliflozin, a diabetes drug, can reduce weight gain caused by antipsychotic medications in people with schizophrenia. About 120 participants will be split into three groups: one gets dapagliflozin plus lifestyle advice, another gets metformin plus lifestyle…
Matched conditions: SCHIZOPHRENIA SPECTRUM AND OTHER PSYCHOTIC DISORDERS
Phase: PHASE4 • Sponsor: Sultan Qaboos University • Aim: Disease control
Last updated May 18, 2026 12:09 UTC